抗癌药物销售强劲,阿斯利康Q2营收同比增12%超预期 | 财报见闻

华尔街见闻
29 Jul

英国制药巨头阿斯利康凭借强劲的抗癌药物销售表现,交出了一份超出市场预期的二季度财报。 据阿斯利康周二发布的财报显示,二季度公司收入达到144.6亿美元,同比增长12%,超过分析师预期的141.5亿美元。核心每股收益达2.17美元,同比增长10%,略超市场预期。 尽管业绩表现亮眼,阿斯利康仍维持全年业绩预期不变,公司表示定价压力和全球贸易风险依然是面临的挑战。同时,公司已宣布计划到2030年在美国...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10